Skip to main content
Erschienen in: Clinical and Translational Oncology 11/2013

01.11.2013 | Research Article

The application of ultrasonic harmonic scalpel in the radical surgery of gastric cancer

verfasst von: Y. Huang, G. C. Mu, X. G. Qin, J. L. Lin, C. Liu, Z. B. Chen, Y. J. Zeng

Erschienen in: Clinical and Translational Oncology | Ausgabe 11/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Ultrasonic harmonic scalpel has been widely applied to laparoscopic surgery of gastric cancer, but it has not been evaluated properly in open surgery. The objective of this study was to evaluate the value of the ultrasonic harmonic scalpel in the open radical surgery of gastric cancer.

Methods

106 gastric cancer patients who had accepted distal D2 lymphadenectomy were included in this study. Patients were divided into ultrasonic harmonic scalpel (UHS) surgery group (50 cases) and conventional electric scalpel surgery group (56 cases). UHS surgery group patients were accepted surgery by ultrasonic harmonic scalpel. Instead, conventional electric scalpel surgery group patients were accepted surgery by monopolar electrocautery shovel and other traditional instruments. Then the average operation time, intra-operative blood loss, number of harvested lymph nodes, average post operative drainage within 3 days, and postoperative hospital stay were collected and compared between the two groups.

Results

The average operation time, blood loss, postoperative hospital stay in UHS group were significantly lower than traditional group (P < 0.05). The number of lymph node dissection was significantly higher than conventional surgery group (P < 0.05). There were no difference between two groups in average drainage within 3 days after surgery and the hospitalization costs (P > 0.05). In the presence of atherosclerotic patients, the average operation time, blood loss in UHS surgery group were significantly lower than the traditional group (P < 0.05).

Conclusion

Ultrasonic harmonic scalpel may have better effect in the radical surgery of gastric cancer patients. It meets the requirements of the future development of precise surgical procedure.
Literatur
1.
Zurück zum Zitat Malekzadeh R, Nasseri-Moghaddam S. Reducing gastric cancer mortality in developing countries: learning from the experience in Japan. Arch Iran Med. 2008;11(5):588–90.PubMed Malekzadeh R, Nasseri-Moghaddam S. Reducing gastric cancer mortality in developing countries: learning from the experience in Japan. Arch Iran Med. 2008;11(5):588–90.PubMed
2.
Zurück zum Zitat Sun X, Mu R, Zhou Y, Dai X, Zhang S, Huang F, et al. Analysis of mortality rate of stomach cancer and its trend in twenty years in China. China J oncol. 2004;26(1):4–9. Sun X, Mu R, Zhou Y, Dai X, Zhang S, Huang F, et al. Analysis of mortality rate of stomach cancer and its trend in twenty years in China. China J oncol. 2004;26(1):4–9.
3.
Zurück zum Zitat Skoropad VIu, Berdov BA. D2 lymphadenectomy for surgical and combined treatment of the gastric cancer. Khirurgiia (Mosk) 2010;(4):26–29. Skoropad VIu, Berdov BA. D2 lymphadenectomy for surgical and combined treatment of the gastric cancer. Khirurgiia (Mosk) 2010;(4):26–29.
4.
Zurück zum Zitat Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver.3). Gastric Cancer. 2011;14(2):113–23.CrossRef Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver.3). Gastric Cancer. 2011;14(2):113–23.CrossRef
5.
Zurück zum Zitat Barbour AP, Rizk NP, Gonen M, Tang L, Bains MS, Rusch VW, et al. Lymphadenectomy for adenocarcinoma of the gastroesophageal junction (GEJ): impact of adequate staging on outcome. Ann Surg Oncol. 2007;14(2):306–16.PubMedCrossRef Barbour AP, Rizk NP, Gonen M, Tang L, Bains MS, Rusch VW, et al. Lymphadenectomy for adenocarcinoma of the gastroesophageal junction (GEJ): impact of adequate staging on outcome. Ann Surg Oncol. 2007;14(2):306–16.PubMedCrossRef
6.
Zurück zum Zitat Yonemura Y, Wu CC, Fukushima N, Honda I, Bandou E, Kawamura T, et al. Randomized clinical trial of D2 and extended paraaortic lymphadenectomy in patients with gastric cancer. Int J Clin Oncol. 2008;13(2):132–7.PubMedCrossRef Yonemura Y, Wu CC, Fukushima N, Honda I, Bandou E, Kawamura T, et al. Randomized clinical trial of D2 and extended paraaortic lymphadenectomy in patients with gastric cancer. Int J Clin Oncol. 2008;13(2):132–7.PubMedCrossRef
7.
Zurück zum Zitat Lee KY, Noh SH, Hyung WJ, Lee JH, Lah KH, Choi SH, et al. Impact of splenectomy for lymph node dissection on long-term surgical outcome in gastric cancer. Ann Surg Oncol. 2001;8(5):402–6.PubMedCrossRef Lee KY, Noh SH, Hyung WJ, Lee JH, Lah KH, Choi SH, et al. Impact of splenectomy for lymph node dissection on long-term surgical outcome in gastric cancer. Ann Surg Oncol. 2001;8(5):402–6.PubMedCrossRef
8.
Zurück zum Zitat Maruyama K, Gunven P, Okabayashi K, Sasako M, Kinoshita T. Lymph node metastases of gastric cancer. General pattern in 1931 patients. Ann Surg. 1989;210(5):596–602.PubMedCrossRef Maruyama K, Gunven P, Okabayashi K, Sasako M, Kinoshita T. Lymph node metastases of gastric cancer. General pattern in 1931 patients. Ann Surg. 1989;210(5):596–602.PubMedCrossRef
9.
Zurück zum Zitat Hiatt JR, Gabbay J, Busuttil RW. Surgical anatomy of the hepatic arteries in 1000 cases. Ann Surg. 1994;220:50–2.PubMedCrossRef Hiatt JR, Gabbay J, Busuttil RW. Surgical anatomy of the hepatic arteries in 1000 cases. Ann Surg. 1994;220:50–2.PubMedCrossRef
10.
Zurück zum Zitat Albanese AM, Albanese EF, Miño JH, Gómez E, Gómez M, Zandomeni M, et al. Peritoneal surface area: measurements of 40 structures covered by peritoneum: correlation between total peritoneal surface area and the surface calculated by formulas. Surg Radiol Anat. 2009;31(5):369–77.PubMedCrossRef Albanese AM, Albanese EF, Miño JH, Gómez E, Gómez M, Zandomeni M, et al. Peritoneal surface area: measurements of 40 structures covered by peritoneum: correlation between total peritoneal surface area and the surface calculated by formulas. Surg Radiol Anat. 2009;31(5):369–77.PubMedCrossRef
Metadaten
Titel
The application of ultrasonic harmonic scalpel in the radical surgery of gastric cancer
verfasst von
Y. Huang
G. C. Mu
X. G. Qin
J. L. Lin
C. Liu
Z. B. Chen
Y. J. Zeng
Publikationsdatum
01.11.2013
Verlag
Springer Milan
Erschienen in
Clinical and Translational Oncology / Ausgabe 11/2013
Print ISSN: 1699-048X
Elektronische ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-013-1026-0

Weitere Artikel der Ausgabe 11/2013

Clinical and Translational Oncology 11/2013 Zur Ausgabe

Educational Series – BLUE SERIES

Has discovery-based cancer research been a bust?

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.